跳至主要内容
临床试验/NCT02894736
NCT02894736已完成不适用

Home-administered Transcranial Direct Current Stimulation (tDCS) Treatment for Depression

The University of New South Wales2 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2016年3月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
34
试验地点
2
主要终点
Montgomery Asberg Depression Rating Scale for Depression (MADRS)

研究概览

简要总结

Transcranial Direct Current Stimulation (tDCS) is a novel non-invasive brain stimulation treatment that is effective with no significant side effects. It can potentially be self-administered by patients in their own homes with remote monitoring, substantially reducing treatment costs and increasing accessibility, including to remote areas. This study will evaluate the feasibility and efficacy of home-administered tDCS treatment for depression.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject meets criteria for a DSM-IV Major Depressive Episode, lasting more than 4 weeks
  • Total MADRS score ≥ 20

排除标准

  • Diagnosis of any DSM-IV psychotic disorder
  • History of drug or alcohol abuse or dependence in the preceding 3 months
  • High suicide risk
  • Clinically defined neurological disorder or insult
  • Metal in the cranium or skull defects
  • Skin lesions on the scalp (e.g. cuts, abrasions, rashes) at the proposed electrode sites
  • Pregnancy

研究组 & 干预措施

Active tDCS

Experimental

Soterix tDCS machine is used to administer active stimulation

干预措施: Soterix tDCS machine (Device)

结局指标

主要结局

Montgomery Asberg Depression Rating Scale for Depression (MADRS)

时间窗: 6 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Colleen Loo

Professor

The University of New South Wales

研究点 (2)

Loading locations...

相似试验